Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Landscape of MS patient cohorts and registries: Recommendations for maximizing impact.

Bebo BF Jr, Fox RJ, Lee K, Utz U, Thompson AJ.

Mult Scler. 2018 Apr;24(5):579-586. doi: 10.1177/1352458517698250. Epub 2017 Mar 1.

2.

A call for transparent reporting to optimize the predictive value of preclinical research.

Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, Crystal RG, Darnell RB, Ferrante RJ, Fillit H, Finkelstein R, Fisher M, Gendelman HE, Golub RM, Goudreau JL, Gross RA, Gubitz AK, Hesterlee SE, Howells DW, Huguenard J, Kelner K, Koroshetz W, Krainc D, Lazic SE, Levine MS, Macleod MR, McCall JM, Moxley RT 3rd, Narasimhan K, Noble LJ, Perrin S, Porter JD, Steward O, Unger E, Utz U, Silberberg SD.

Nature. 2012 Oct 11;490(7419):187-91. doi: 10.1038/nature11556.

3.

Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 1996. 384: 134-141.

Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC.

J Immunol. 2010 Dec 1;185(11):6394-401. No abstract available.

4.

Biomarkers in multiple sclerosis.

Martin R, Bielekova B, Hohlfeld R, Utz U.

Dis Markers. 2006;22(4):183-5. No abstract available.

5.

Immunomodulation strategies for preventing vascular disease of the brain and heart: workshop summary.

Hallenbeck J, Del Zoppo G, Jacobs T, Hakim A, Goldman S, Utz U, Hasan A; Immunomodulation Workshop Participants.

Stroke. 2006 Dec;37(12):3035-42. Epub 2006 Nov 2.

6.

Detection of human T-lymphotropic virus (HTLV) tax sequences in New York City blood donors seronegative for HTLV types 1 and 2.

Dezzutti CS, Guenthner PC, Daniel S, Utz U, Cabrera T, Marshall JH, Bianco C, Lal RB, Cowan EP.

Clin Diagn Lab Immunol. 2003 Jul;10(4):715-7.

7.

Molecular tracking of antigen-specific T cell clones in neurological immune-mediated disorders.

Muraro PA, Wandinger KP, Bielekova B, Gran B, Marques A, Utz U, McFarland HF, Jacobson S, Martin R.

Brain. 2003 Jan;126(Pt 1):20-31.

8.

Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures.

Hausmann S, Biddison WE, Smith KJ, Ding YH, Garboczi DN, Utz U, Wiley DC, Wucherpfennig KW.

J Immunol. 1999 May 1;162(9):5389-97.

9.

Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids.

Ding YH, Smith KJ, Garboczi DN, Utz U, Biddison WE, Wiley DC.

Immunity. 1998 Apr;8(4):403-11.

10.

Longitudinal study of myelin basic protein-specific T-cell receptors during the course of multiple sclerosis.

Lovett-Racke AE, Martin R, McFarland HF, Racke MK, Utz U.

J Neuroimmunol. 1997 Sep;78(1-2):162-71.

PMID:
9307241
11.

Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors.

O'Herrin SM, Lebowitz MS, Bieler JG, al-Ramadi BK, Utz U, Bothwell AL, Schneck JP.

J Exp Med. 1997 Oct 20;186(8):1333-45.

12.

Human T cell leukemia virus type I (HTLV-I)-specific CD8+ CTL clones from patients with HTLV-I-associated neurologic disease secrete proinflammatory cytokines, chemokines, and matrix metalloproteinase.

Biddison WE, Kubota R, Kawanishi T, Taub DD, Cruikshank WW, Center DM, Connor EW, Utz U, Jacobson S.

J Immunol. 1997 Aug 15;159(4):2018-25.

PMID:
9257869
13.

Assembly, specific binding, and crystallization of a human TCR-alphabeta with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2.

Garboczi DN, Utz U, Ghosh P, Seth A, Kim J, VanTienhoven EA, Biddison WE, Wiley DC.

J Immunol. 1996 Dec 15;157(12):5403-10.

PMID:
8955188
14.

Structure of the complex between human T-cell receptor, viral peptide and HLA-A2.

Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC.

Nature. 1996 Nov 14;384(6605):134-41.

PMID:
8906788
15.

Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99).

Vergelli M, Hemmer B, Utz U, Vogt A, Kalbus M, Tranquill L, Conlon P, Ling N, Steinman L, McFarland HF, Martin R.

Eur J Immunol. 1996 Nov;26(11):2624-34.

PMID:
8921948
17.

Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein.

Brocke S, Gijbels K, Allegretta M, Ferber I, Piercy C, Blankenstein T, Martin R, Utz U, Karin N, Mitchell D, Veromaa T, Waisman A, Gaur A, Conlon P, Ling N, Fairchild PJ, Wraith DC, O'Garra A, Fathman CG, Steinman L.

Nature. 1996 Jan 25;379(6563):343-6. Erratum in: Nature 1998 Apr 9;392(6676):630.

PMID:
8552189
19.

T-cell receptor use in multiple sclerosis.

Utz U, Martin R, Brooks JA, Biddison WE, McFarland HF.

Ann N Y Acad Sci. 1995 Jul 7;756:259-64. No abstract available.

PMID:
7544076
20.

The role of T cells in multiple sclerosis: implications for therapies targeting the T cell receptor.

Utz U, McFarland HF.

J Neuropathol Exp Neurol. 1994 Jul;53(4):351-8. Review.

PMID:
8021708
21.
22.

Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis.

Utz U, Biddison WE, McFarland HF, McFarlin DE, Flerlage M, Martin R.

Nature. 1993 Jul 15;364(6434):243-7.

PMID:
7686632
23.

Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells.

Zweerink HJ, Gammon MC, Utz U, Sauma SY, Harrer T, Hawkins JC, Johnson RP, Sirotina A, Hermes JD, Walker BD, et al.

J Immunol. 1993 Mar 1;150(5):1763-71.

PMID:
7679694
24.

Sequence motifs important for peptide binding to the human MHC class I molecule, HLA-A2.

Parker KC, Bednarek MA, Hull LK, Utz U, Cunningham B, Zweerink HJ, Biddison WE, Coligan JE.

J Immunol. 1992 Dec 1;149(11):3580-7.

PMID:
1331239
27.
28.

Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106.

Martin R, Utz U, Coligan JE, Richert JR, Flerlage M, Robinson E, Stone R, Biddison WE, McFarlin DE, McFarland HF.

J Immunol. 1992 Mar 1;148(5):1359-66.

PMID:
1371525
29.

Identification of a neutralizing epitope on glycoprotein gp58 of human cytomegalovirus.

Utz U, Britt W, Vugler L, Mach M.

J Virol. 1989 May;63(5):1995-2001.

30.

Mapping of the major glycoprotein gene of human cytomegalovirus.

Mach M, Utz U, Fleckenstein B.

J Gen Virol. 1986 Jul;67 ( Pt 7):1461-7.

PMID:
2873201

Supplemental Content

Support Center